Welcome to MPN!
The Penn Center for Myeloproliferative Neoplasms and Mast Cell Disorders is a nationally recognized program providing comprehensive clinical care for patients with myeloproliferative neoplasms, including systemic mast cell disorders. We work hard to enable access to the latest clinical trials, and to serve as an educational resource for patients and healthcare providers.
Myeloproliferative neoplasms are rare blood disorders, which can be challenging to diagnose and nuanced to treat. Since Penn's discovery of the Philadelphia Chromosome, which revolutionized treatment of chronic myeloid leukemia, Penn has led the way in treatment of myeloproliferative disorders. Under the guidance of Dr. Elizabeth Hexner, Penn has established a comprehensive team of expert hematologists, hematopathologists, molecular diagnostics specialists, bone marrow transplant physicians, advanced practice nurses and pharmacists who work together to develop a personalized treatment plan drawing upon decades of experience.
Penn MPN and Mast Cell Disorders Program Physicians treat all types of myeloproliferative disorders, including:
- Acute Leukemia arising from MPN
- Chronic Eosinophilic Leukemia
- Chronic Myeloid Leukemia
- Essential Thrombocythemia
- Myeloproliferative/Myelodysplastic Syndromes
- Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB OR FGFR1
- Polycythemia Vera
- Systemic Mastocytosis
Penn Myeloproliferative Neoplasms Weekly Case Conference and Journal Club
Wednesdays, 11:30 AM
PCAM3 South Conference Room
Abramson Cancer Center Update in Hematologic Malignancies with Proceedings from International Meetings
Saturday, January 30, 2016, 8am – 4pm
The Hub Cira Centre